296 related articles for article (PubMed ID: 33824339)
1. Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia.
Olson B; Zhu X; Norgard MA; Levasseur PR; Butler JT; Buenafe A; Burfeind KG; Michaelis KA; Pelz KR; Mendez H; Edwards J; Krasnow SM; Grossberg AJ; Marks DL
Nat Commun; 2021 Apr; 12(1):2057. PubMed ID: 33824339
[TBL] [Abstract][Full Text] [Related]
2. Lcn2 mediates adipocyte-muscle-tumor communication and hypothermia in pancreatic cancer cachexia.
Lemecha M; Chalise JP; Takamuku Y; Zhang G; Yamakawa T; Larson G; Itakura K
Mol Metab; 2022 Dec; 66():101612. PubMed ID: 36243318
[TBL] [Abstract][Full Text] [Related]
3. MC4R-dependent suppression of appetite by bone-derived lipocalin 2.
Mosialou I; Shikhel S; Liu JM; Maurizi A; Luo N; He Z; Huang Y; Zong H; Friedman RA; Barasch J; Lanzano P; Deng L; Leibel RL; Rubin M; Nickolas T; Chung W; Zeltser LM; Williams KW; Pessin JE; Kousteni S
Nature; 2017 Mar; 543(7645):385-390. PubMed ID: 28273060
[TBL] [Abstract][Full Text] [Related]
4. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.
Burfeind KG; Zhu X; Norgard MA; Levasseur PR; Huisman C; Buenafe AC; Olson B; Michaelis KA; Torres ER; Jeng S; McWeeney S; Raber J; Marks DL
Elife; 2020 May; 9():. PubMed ID: 32391790
[TBL] [Abstract][Full Text] [Related]
5. LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia.
Wang D; Li X; Jiao D; Cai Y; Qian L; Shen Y; Lu Y; Zhou Y; Fu B; Sun R; Tian Z; Zheng X; Wei H
J Hematol Oncol; 2023 Mar; 16(1):30. PubMed ID: 36973755
[TBL] [Abstract][Full Text] [Related]
6. Adipokines in patients with cancer anorexia and cachexia.
Smiechowska J; Utech A; Taffet G; Hayes T; Marcelli M; Garcia JM
J Investig Med; 2010 Mar; 58(3):554-9. PubMed ID: 20215915
[TBL] [Abstract][Full Text] [Related]
7. Lipocalin 2-A bone-derived anorexigenic and β-cell promoting signal: From mice to humans.
Yang Y; Liu J; Kousteni S
J Diabetes; 2024 Mar; 16(3):e13504. PubMed ID: 38035773
[TBL] [Abstract][Full Text] [Related]
8. Critical changes in hypothalamic gene networks in response to pancreatic cancer as found by single-cell RNA sequencing.
Huisman C; Norgard MA; Levasseur PR; Krasnow SM; van der Wijst MGP; Olson B; Marks DL
Mol Metab; 2022 Apr; 58():101441. PubMed ID: 35031523
[TBL] [Abstract][Full Text] [Related]
9. Peripheral-central network analysis of cancer cachexia status accompanied by the polarization of hypothalamic microglia with low expression of inhibitory immune checkpoint receptors.
Suda Y; Nakamura K; Matsuyama F; Hamada Y; Makabe H; Narita M; Nagumo Y; Mori T; Kuzumaki N; Narita M
Mol Brain; 2024 Apr; 17(1):20. PubMed ID: 38685046
[TBL] [Abstract][Full Text] [Related]
10. Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss.
Garnsey MR; Smith AC; Polivkova J; Arons AL; Bai G; Blakemore C; Boehm M; Buzon LM; Campion SN; Cerny M; Chang SC; Coffman K; Farley KA; Fonseca KR; Ford KK; Garren J; Kong JX; Koos MRM; Kung DW; Lian Y; Li MM; Li Q; Martinez-Alsina LA; O'Connor R; Ogilvie K; Omoto K; Raymer B; Reese MR; Ryder T; Samp L; Stevens KA; Widlicka DW; Yang Q; Zhu K; Fortin JP; Sammons MF
J Med Chem; 2023 Mar; 66(5):3195-3211. PubMed ID: 36802610
[TBL] [Abstract][Full Text] [Related]
11. Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment.
Gomez-Chou SB; Swidnicka-Siergiejko AK; Badi N; Chavez-Tomar M; Lesinski GB; Bekaii-Saab T; Farren MR; Mace TA; Schmidt C; Liu Y; Deng D; Hwang RF; Zhou L; Moore T; Chatterjee D; Wang H; Leng X; Arlinghaus RB; Logsdon CD; Cruz-Monserrate Z
Cancer Res; 2017 May; 77(10):2647-2660. PubMed ID: 28249896
[TBL] [Abstract][Full Text] [Related]
12. MyD88 signalling is critical in the development of pancreatic cancer cachexia.
Zhu X; Burfeind KG; Michaelis KA; Braun TP; Olson B; Pelz KR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):378-390. PubMed ID: 30666818
[TBL] [Abstract][Full Text] [Related]
13. Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia.
Zhu X; Callahan MF; Gruber KA; Szumowski M; Marks DL
J Clin Invest; 2020 Sep; 130(9):4921-4934. PubMed ID: 32544087
[TBL] [Abstract][Full Text] [Related]
14. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
15. TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia.
Greco SH; Tomkötter L; Vahle AK; Rokosh R; Avanzi A; Mahmood SK; Deutsch M; Alothman S; Alqunaibit D; Ochi A; Zambirinis C; Mohaimin T; Rendon M; Levie E; Pansari M; Torres-Hernandez A; Daley D; Barilla R; Pachter HL; Tippens D; Malik H; Boutajangout A; Wisniewski T; Miller G
PLoS One; 2015; 10(7):e0132786. PubMed ID: 26172047
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia.
Deng M; Aberle MR; van Bijnen AAJHM; van der Kroft G; Lenaerts K; Neumann UP; Wiltberger G; Schaap FG; Olde Damink SWM; Rensen SS
Front Immunol; 2023; 14():1159411. PubMed ID: 37006254
[TBL] [Abstract][Full Text] [Related]
17. Update on melanocortin interventions for cachexia: progress toward clinical application.
DeBoer MD
Nutrition; 2010 Feb; 26(2):146-51. PubMed ID: 20004082
[TBL] [Abstract][Full Text] [Related]
18. Lipocalin 2 - mutation screen and serum levels in patients with anorexia nervosa or obesity and in lean individuals.
Zheng Y; Rajcsanyi LS; Kowalczyk M; Giuranna J; Herpertz-Dahlmann B; Seitz J; de Zwaan M; Herzog W; Ehrlich S; Zipfel S; Giel K; Egberts K; Burghardt R; Föcker M; Al-Lahham S; Hebebrand J; Fuhrer D; Tan S; Zwanziger D; Peters T; Hinney A
Front Endocrinol (Lausanne); 2023; 14():1137308. PubMed ID: 37025415
[TBL] [Abstract][Full Text] [Related]
19. Weight loss is not associated with hyperleptinemia in humans with pancreatic cancer.
Brown DR; Berkowitz DE; Breslow MJ
J Clin Endocrinol Metab; 2001 Jan; 86(1):162-6. PubMed ID: 11231995
[TBL] [Abstract][Full Text] [Related]
20. Melanocortin-4 Receptor and Lipocalin 2 Gene Variants in Spanish Children with Abdominal Obesity: Effects on BMI-SDS After a Lifestyle Intervention.
Morell-Azanza L; Ojeda-Rodríguez A; Giuranna J; Azcona-SanJulián MC; Hebebrand J; Marti A; Hinney A
Nutrients; 2019 Apr; 11(5):. PubMed ID: 31035493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
